The protein language models market is projected to reach $3.05B by 2030 at a 25.7% CAGR, driven by AI-driven protein design, cloud modeling platforms, and accelerated drug discovery workflows.
Read More
The prion disease treatment market is projected to reach $4.15B by 2030 at 6.6% CAGR, driven by precision neurology, novel drug discovery, and advanced prion diagnostics.
Read More
The pharmaceutical quality control release testing market is projected to reach $11.01B by 2030 at 7.9% CAGR, driven by biologics growth, regulatory audits, and AI-enabled QC services.
Read More
The personal genome services market is projected to reach $13.69 billion by 2030 at a 14.9% CAGR, driven by preventive genomics, pharmacogenomics, and digital health integration.
Read More
The orthostatic hypotension market is projected to reach $1.62 billion by 2030 at an 8.6% CAGR, driven by remote monitoring, telehealth, and wearable blood pressure technologies.
Read More
The oligonucleotide synthesis services market is projected to reach $4.7 billion by 2030 at a 10.0% CAGR, driven by gene therapy, CRISPR demand, and GMP oligo production.
Read More
The medical imaging outsourcing market is set to reach $27.88 billion by 2030 at a 9.1% CAGR, driven by teleradiology, remote diagnostics, and faster reporting demand.
Read More
Tumor Profiling market size is expected to reach $17.96 by 2030 at 9.9%, driven by rising demand for personalized medicine.
Read More
The global Tumor Microenvironment market will grow from $2.73 billion in 2024 to $2.44 billion in 2030 at 12.1% CAGR, driven by advancements in oncology and immunotherapy technologies.
Read More
The global tumor marker testing market to reach $27.23 billion by 2030 at 7.9% cagr, driven by increasing cancer prevalence.
Read More